Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02524977 · ClinicalTrials.gov registry record · NA

Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation

A NA study of Atrial Fibrillation and Atrial Flutter, sponsored by University of Cincinnati.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT02524977: Completed NA study of Atrial Fibrillation and Atrial Flutter, sponsored by University of Cincinnati.

NCT02524977 is a NA study of Atrial Fibrillation and Atrial Flutter that has completed, run by University of Cincinnati. The registered enrollment target is 70 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02524977, a NA study of Atrial Fibrillation and Atrial Flutter, has completed, sponsored by University of Cincinnati.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Study objective was to improve decision-making and thromboprophylaxis for patients with Atrial Fibrillation (AF) by developing and implementing a computerized decision support tool for individual patient-level decision-making about oral anticoagulant therapy. To accomplish these goals, the investigators studied the incremental impact of adding a quality-improvement (QI) intervention to an educational package (for practice staff and clinicians) using a computerized aid, the Atrial Fibrillation Decision Support Tool (AFDST) for individual patient-level decision-making about oral anticoagulant therapy in patients with non-valvular AF. The decision support tool incorporates individual patients' risk factor profiles for ischemic stroke and bleeding and provides a recommendation for treatment based upon the projected quality-adjusted life expectancy gained or lost with the addition of either oral anticoagulant therapy or aspirin compared with no thromboprophylaxis.

Primary Outcome

Changes in the proportion of patients with current therapy that was discordant from the decision support tool recommendation between the start and finish date of the study (one year period).

Interventions

  • BEHAVIORAL Decision Support
  • BEHAVIORAL Educational Intervention Only

Study Locations (1)

Ohio

  • Primary Care Practices of UC Health - Cincinnati

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2012-12
Est. Completion 2016-03
Phase NA
University of Cincinnati

245 total trials

What the finished NCT02524977 record still lists

NCT02524977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Decision Support is the first listed.

NCT02524977 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02524977 about?

NCT02524977 is a clinical study titled "Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation". Study objective was to improve decision-making and thromboprophylaxis for patients with Atrial Fibrillation (AF) by developing and implementing a computerized decision support tool for individual patient-level decision-making about oral anticoagulant therapy. To accomplish these goals, the investiga...

What is the current status of trial NCT02524977?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2012-12. Estimated completion is 2016-03.

What conditions does trial NCT02524977 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter.

What interventions are being tested in trial NCT02524977?

The interventions under investigation include: Decision Support (BEHAVIORAL), Educational Intervention Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT02524977?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02524977 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02524977's enrollment target sits among peer trials

70 160th of 202 higher than 43 of 202 other Atrial Fibrillation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02524977, the US trial registry maintained by the National Library of Medicine. NCT02524977 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.